TL;DR
This study reveals a critical link between disrupted circadian rhythms, specifically the loss of the BMAL1 protein, and glucocorticoid (GC) resistance in asthma. By uncovering the DUSP4-p38MAPK pathway as a mediator, the research identifies a novel therapeutic target for improving GC efficacy in patients with asthma, particularly those with sleep disturbances.
What Problem Does This Paper Address?
Asthma is a widespread chronic inflammatory disease, and while glucocorticoids (GCs) are the cornerstone of its management, a significant portion of patients exhibit steroid-resistant asthma (SRA). This resistance severely compromises disease control and worsens prognosis. While various mechanisms for GC resistance have been proposed, the role of circadian rhythm disruption, a common issue in asthma patients, has been increasingly implicated but the precise molecular link remained unclear. This paper aims to elucidate how disruptions in the body's internal clock, specifically the BMAL1 protein, contribute to GC resistance in airway epithelial cells during house dust mite (HDM)-induced asthma.
Methods
The researchers employed a multi-pronged approach:
- Clinical Data Analysis: They collected data from asthma patients, assessing chronotype (using the Morningness Eveningness Questionnaire - MEQ-SA) and asthma control (using the Asthma Control Test - ACT).
- In Vitro Studies: They used human bronchial epithelial cells (HBECs) and manipulated BMAL1 levels using siRNA (knockdown) and overexpression. They then assessed inflammatory markers, GC-responsive gene expression, and the phosphorylation status of the glucocorticoid receptor (GR).
- In Vivo Animal Models: They utilized BMAL1 knockout (Bmal1-/-) mice and wild-type (WT) mice, inducing HDM-driven asthma. They also employed a sleep deprivation (SD) model in mice to mimic circadian disruption. Various histological analyses (H&E, Masson, PAS staining) and BALF analysis were performed.
- Molecular Pathway Analysis: Techniques like RNA sequencing, Western blotting, immunofluorescence microscopy, and chromatin immunoprecipitation (ChIP) assays were used to investigate gene expression, protein levels, signaling pathways (NF-κB, AP-1, p38MAPK), and protein-protein interactions.
- Therapeutic Intervention: They tested the efficacy of a DUSP4 inhibitor (BCI) in combination with DEX in both in vitro and in vivo models.
Datasets
- Clinical Data: Data from 70 asthma patients collected between September 2023 and September 2024 at Nanfang Hospital, Southern Medical University.
- Publicly Available Transcriptomic Data: GSE74986 dataset from the GEO database, containing transcriptomic data from bronchial exfoliating cells of human samples.
Key Insights and Ideas
- Circadian Disruption Fuels Asthma Severity: The study strongly suggests that disrupted circadian rhythms, particularly in individuals with a "late chronotype," are associated with poorer asthma control and increased reliance on GC therapy.
- BMAL1 as a Guardian Against GC Resistance: Loss of BMAL1, a key circadian clock component, directly exacerbates HDM-induced airway inflammation and, crucially, leads to GC resistance in airway epithelial cells. This implies BMAL1 plays a protective role in maintaining GC sensitivity.
- The DUSP4-p38MAPK-GR Axis is Central: The research pinpoints a specific molecular pathway: BMAL1 normally represses DUSP4, a phosphatase. When BMAL1 is lost, DUSP4 is upregulated, which in turn inhibits p38MAPK. This reduced p38MAPK activity then leads to decreased phosphorylation of the GR at Ser211, a critical step for GC efficacy.
- Targeting DUSP4 Offers Hope: Inhibiting DUSP4 effectively restored p38MAPK activity and GR phosphorylation in BMAL1-deficient cells and mice, thereby reversing GC resistance. This highlights DUSP4 as a promising therapeutic target.
- Human Relevance: Elevated DUSP4 expression was observed in airway epithelium of patients with severe asthma, further validating the clinical relevance of this pathway.
Key Results
- Patients with late chronotypes showed significantly worse asthma control and higher exacerbation rates.
- BMAL1 deficiency in mice led to more severe airway inflammation, increased inflammatory cell infiltration, and elevated pro-inflammatory cytokines.
- In vitro, BMAL1 knockdown in HBECs diminished the anti-inflammatory effects of dexamethasone (DEX) and reduced the expression of GC-responsive genes.
- BMAL1 deficiency led to decreased phosphorylation of GR at Ser211 and suppressed p38MAPK activation.
- Inhibition of DUSP4 with BCI restored GR-Ser211 and p38MAPK phosphorylation in BMAL1-deficient cells and mice, improving GC responsiveness.
- Human bronchial biopsies from severe asthma patients showed higher DUSP4 expression.
Limitations and Future Work
- In Vitro Model Limitations: The study used immortalized HBEC cultures, which may not fully replicate the complexity of primary pseudostratified columnar epithelium. Future work could explore primary cell models.
- Focus on Epithelial Cells: The research primarily focused on airway epithelial cells. However, other immune cells (ILC3, Th17, M1 macrophages) also play a role in GC resistance, and their involvement in the context of circadian disruption warrants further investigation.
- Sleep Deprivation Model: While useful, the sleep deprivation model in mice is a surrogate for circadian disruption and doesn't fully capture central circadian clock dysfunction. Future studies could incorporate SCN-targeted analyses or clock gene reporter systems.
- Therapeutic Agent Properties: The DUSP4 inhibitor BCI is noted as a tool compound with limitations in pharmacokinetic properties. Further development of more refined DUSP4-targeted therapies is needed.
- ERK Pathway Activation: The study observed significant activation of the ERK pathway upon BMAL1 knockdown. The specific role of this pathway in circadian disruption-related asthma requires further investigation.
Overall, this study provides a compelling mechanistic link between circadian clock disruption and GC resistance in asthma, opening avenues for novel therapeutic strategies that target the DUSP4-p38MAPK-GR axis.
Summary updated